Kuo-Hsiang Chuang Selected Research

tetra-n-butyl ammonium salt p-hydroxyaniline mustard glucuronide

5/2006

Combination cancer therapy by hapten-targeted prodrug-activating enzymes and cytokines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kuo-Hsiang Chuang Research Topics

Disease

19	Neoplasms (Cancer) 06/2022 - 05/2006
2	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2016
2	Endometriosis 07/2021 - 05/2019
2	Rheumatoid Arthritis 01/2019 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 02/2015
1	Cytokine Release Syndrome 01/2022
1	Bites and Stings (Sting) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 09/2021
1	Diarrhea 09/2021
1	Nausea 09/2021
1	Infections 01/2019
1	Listeriosis (Listeria Infection) 01/2019
1	Necrosis 01/2019
1	Infectious Arthritis (Septic Arthritis) 01/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Pathologic Processes 12/2017
1	Triple Negative Breast Neoplasms 01/2017
1	Adenocarcinoma 06/2015
1	Breast Ductal Carcinoma 06/2015
1	Burkitt Lymphoma (Burkitt's Lymphoma) 06/2015
1	Carcinogenesis 01/2015

Drug/Important Bio-Agent (IBA)

5	GlucuronidaseIBA 02/2022 - 09/2009
5	monomethoxypolyethylene glycol (MPEG)IBA 01/2022 - 12/2014
4	AntibodiesIBA 06/2022 - 06/2015
4	Pharmaceutical PreparationsIBA 01/2022 - 12/2014
4	GlucuronidesIBA 01/2015 - 05/2006
3	liposomal doxorubicin (Doxil)FDA Link 12/2021 - 12/2014
3	Liposomes (Liposome)IBA 12/2021 - 06/2015
3	Estrogens (Estrogen)FDA Link 07/2021 - 12/2017
3	AntigensIBA 01/2021 - 12/2014
3	Bispecific AntibodiesIBA 01/2021 - 12/2014
2	compound 17IBA 06/2022 - 03/2020
2	CytokinesIBA 06/2022 - 05/2006
2	B7-H1 AntigenIBA 01/2022 - 03/2020
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 01/2016
2	Docetaxel (Taxotere)FDA Link 01/2021 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2015
2	ProdrugsIBA 02/2012 - 05/2006
1	Oncogene Proteins (Oncogene Protein)IBA 06/2022
1	Granzymes (Granzyme)IBA 06/2022
1	HydrogelsIBA 11/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2021
1	Bevacizumab (Avastin)FDA Link 09/2021
1	SilymarinIBA 09/2021
1	Cytotoxins (Cytolysins)IBA 09/2021
1	7-ethyl-10-hydroxycamptothecin beta-glucuronideIBA 09/2021
1	Topoisomerase InhibitorsIBA 09/2021
1	Interleukin-33IBA 07/2021
1	ferric oxide (iron oxide)IBA 08/2020
1	AfatinibIBA 03/2020
1	Anti-Idiotypic AntibodiesIBA 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	Hormones (Hormone)IBA 12/2017
1	LigandsIBA 01/2016
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	LipidsIBA 01/2016
1	Immunoglobulin G (IgG)IBA 06/2015
1	Biological ProductsIBA 02/2015
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 02/2015
1	CarcinogensIBA 01/2015
1	Fluorescein-5-isothiocyanate (FITC)IBA 02/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2012
1	Peptide Hydrolases (Proteases)FDA Link 01/2012
1	Phenolphthalein (Modane)IBA 09/2009
1	1- myristoyl- 2- (12- ((5- dimethylamino- 1- naphthalenesulfonyl)amino)dodecanoyl)- sn- glycero- 3- phosphocholineIBA 05/2006
1	Aniline MustardIBA 05/2006
1	EnzymesIBA 05/2006
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 05/2006
1	Single-Chain AntibodiesIBA 05/2006
1	HaptensIBA 05/2006
1	tetra-n-butyl ammonium salt p-hydroxyaniline mustard glucuronideIBA 05/2006

Therapy/Procedure

10	Therapeutics 01/2022 - 05/2006
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Injections 11/2021
1	Intravenous Administration 05/2006